packageAmivantamab

amivantamab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Amivantamab is a monoclonal antibody used to treat non-small-cell lung cancer. It is an approved anticancer medicine authorised in the European Union, and is also being studied for other uses.

Summary written by glm-5.3-flash from Wikidata Q106957199 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:amivantamab
ATC codes:L01FX18
DrugBank:DB16695
Wikidata:Q106957199
molar mass:148000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown